SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConvaTec Regulatory News (CTEC)

Share Price Information for ConvaTec (CTEC)

Share Price is delayed by 15 minutes
Get Live Data
202.60    2.60 (1.30%)
Bid:
203.20
Ask:
203.60
Spread: 0.40 (0.197%)
Market Cap: £3.96b
CTEC Live PriceLast checked at - London Stock Exchange

Intraday ConvaTec Share Chart

Stabilisation Notice

26 Oct 2016 07:00

RNS Number : 4526N
ConvaTec Group PLC
26 October 2016
 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

ConvaTec Group plc (the "Company")

Stabilisation Notice

26 October 2016

Goldman Sachs International (contact: Craig Loftus; telephone: +44 (0)20 7774 1000) hereby gives notice that the Stabilising Manager named below and its affiliates may stabilise the offer of the following securities in accordance with the relevant provisions of the Market Abuse Regulation (EU) No 596/2014 and Commission Delegated Regulation (EU) 2016/1052.

The securities:

Issuer:

ConvaTec Group plc

Securities:

Ordinary shares ("ORDs") of the Issuer (ISIN: GB00BD3VFW73)

Offering size:

659,734,996

Offer price:

225p

Stabilisation:

Stabilising Manager:

Goldman Sachs International, Peterborough Court, 133 Fleet Street, London EC4A 2BB

Stabilisation period expected to start on:

26 October 2016 at 8:00am

Stabilisation period expected to end no later than:

25 November 2016 (close of business)

Maximum size of over-allotment facility:

15% of global offer

Trading venue where stabilisation may be undertaken:

London Stock Exchange

Over-allotment Option:

Terms:

The Over-allotment Shareholders have granted Goldman Sachs International, in its capacity as Stabilising Manager and for the account of the underwriters, the option to acquire up to an additional 98,960,249 ORDs at the Offer price.

Duration:

This option may be executed at any time during the stabilisation period.

 

Disclaimer

 

In connection with the offer of the above securities, the Stabilising Manager may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager will take any stabilisation action and any stabilisation action, if begun, may be ended at any time.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States. The distribution of this announcement in other jurisdictions may be restricted by law, and persons whose possession this announcement comes into should inform themselves about, and observe, such restrictions.

 

END

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STAPGGPAUUPQUUQ
Date   Source Headline
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20254:45 pmRNSDirector/PDMR Shareholding
4th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 20255:16 pmRNSTotal Voting Rights
1st Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 20259:10 amRNSDirector/PDMR Shareholding
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 202512:16 pmRNSHolding(s) in Company
26th Aug 20257:00 amRNSTransaction in Own Shares
21st Aug 20257:00 amRNSTransaction in Own Shares
20th Aug 20257:00 amRNSConvatec commences share buyback programme
18th Aug 202511:09 amRNSHolding(s) in Company
11th Aug 202510:33 amRNSHolding(s) in Company
8th Aug 20257:00 amRNSDirector/PDMR Shareholding
4th Aug 20257:00 amRNSUpdate regarding Chief Executive Officer
1st Aug 202512:18 pmRNSHolding(s) in Company
29th Jul 20257:00 amRNSInterim Results
24th Jul 20251:04 pmRNSHolding(s) in Company
15th Jul 20257:34 amRNSConvatec responds to draft CMS proposal
26th Jun 202510:30 amRNSHolding(s) in Company
2nd Jun 20253:45 pmRNSDirector/PDMR Shareholding
22nd May 20254:25 pmRNSResults of AGM
22nd May 20257:00 amRNSAGM Trading Update
29th Apr 20253:15 pmRNSHolding(s) in Company
29th Apr 20252:21 pmRNSHolding(s) in Company
28th Apr 20253:07 pmRNSHolding(s) in Company
14th Apr 20257:00 amRNSConvatec responds to LCDs postponement in US
3rd Apr 20253:21 pmRNSHolding(s) in Company
18th Mar 20255:51 pmRNSDirector/PDMR Shareholding
18th Mar 20255:45 pmRNSDirector/PDMR Shareholding
12th Mar 202512:00 pmRNSDirector/PDMR Shareholding
11th Mar 20259:00 amRNSPublication of Annual Report and Notice of AGM
26th Feb 20257:00 amRNSConvatec FY24 Results
15th Nov 202411:53 amRNSHolding(s) in Company
14th Nov 20245:52 pmRNSConvatec responds to LCDs in the United States
12th Nov 20247:00 amRNSTrading update for 10 months ended 31 October 2024
6th Nov 20249:00 amRNSHolding(s) in Company
15th Oct 20249:45 amRNSHolding(s) in Company
19th Aug 20243:17 pmRNSNotification of Major Holdings
2nd Aug 20242:39 pmRNSHoldings in Company
1st Aug 202410:12 amRNSDirector Declaration
30th Jul 20247:00 amRNSInterim Results
20th May 20243:39 pmRNSHolding(s) in Company
16th May 20245:00 pmRNSConvatec Group PLC: Results of AGM
16th May 20247:00 amRNSAGM Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.